Emergence of Resistance to Daptomycin during Treatment of Vancomycin-Resistant Enterococcus faecalis Infection
Open Access
- 15 August 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (4) , 565-566
- https://doi.org/10.1086/432121
Abstract
SIR—Daptomycin is a recently approved antibiotic intended for the treatment of complicated soft-tissue infection. It has in vitro bactericidal activity againstKeywords
This publication has 9 references indexed in Scilit:
- Antimicrobial activity of daptomycin against multidrug-resistant gram-positive strains collected worldwideDiagnostic Microbiology and Infectious Disease, 2004
- Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive PathogensClinical Infectious Diseases, 2004
- Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infectionsJournal of Antimicrobial Chemotherapy, 2003
- Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001Antimicrobial Agents and Chemotherapy, 2003
- Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.Journal of Antimicrobial Chemotherapy, 2003
- Resistance Studies with DaptomycinAntimicrobial Agents and Chemotherapy, 2001
- Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive PathogensAntimicrobial Agents and Chemotherapy, 2000
- Rapid preparation of bacterial DNA for pulsed-field gel electrophoresisJournal of Clinical Microbiology, 1996